USPTO serial 98313402
DIGITAL PILL
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- CHUNG, ABBIE
- Law office
- TMO LAW OFFICE 115
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with DIGITAL PILL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Scotts Valley, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mark I. Koffsky
Mark I. Koffsky Koffsky Schwalb LLC500 Seventh Avenue, 8th FloorNew York, NY 10018United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable software as a Medical Device (SaMD) for treating neuropsychiatric disorders, namely, depression, anxiety disorders, OCD, substance use disorders, PTSD, cognitive disorders, and sensorimotor deficits; Downloadable computer software for controlling and managing patient medical information; Downloadable medical software as a medical device (SaMD) for treatment of neuropsychiatric disorders, namely, depression, anxiety disorders, OCD, substance use disorders, PTSD, cognitive disorders, and sensorimotor deficits; Computer hardware and recorded software sold as a unit for use with electrocorticographic stimulation devices, for receiving, processing, transmitting and displaying data; Interfaces for computers, namely a device providing wireless power to implants allowing patients to interface with computer hardware sharing brain activity; Wearable computer peripherals in the form of a device providing wireless power to implants; Downloadable software for connecting, operating, and managing networked hardware devices, namely, implants, a device providing wireless power to implants, computer hardware, phones, laptops, desktops, tablets, smartwatches, smartrings, headsets wearable devices in the internet of things (IoT); Microcontrollers for internet of things (IoT) enabled devices; Downloadable computer software for operating therapeutic, diagnostic and rehabilitation medical systems, namely, computer software to measure biometric data for diagnosing and treating neuropsychiatric disorders, namely depression, anxiety disorders, OCD, substance use disorders, PTSD, addiction, cognitive disorders, sensorimotor deficits; Downloadable computer software in the field of data management for processing medical data, patient data, and demographic data, namely, data acquisition, data visualization, automatic data analysis, statistic data analysis, automated report generation, comparative data analysis, data export/import, data searching, data synchronization tools, using artificial intelligence | ACTIVE | — |
| 010 | Implants consisting of artificial materials; Wearable monitors used to measure biometric data for medical use; Medical devices for use in treating or diagnosing neuropsychiatric disorders, namely, depression, anxiety disorders, OCD, substance use disorders, PTSD, cognitive disorders, and sensorimotor deficits, with integrated recorded operating system software, sold as a unit; Surgical and medical apparatus and instruments, namely, electrocorticographic stimulation apparatus for the treatment of neuropsychiatric disorders including depression, anxiety disorders, OCD, substance use disorders, PTSD, cognitive disorders, and sensorimotor deficits; Non-invasive electronic neuromodulator device for medical use, namely, for the treatment of neuropsychiatric disorders including depression, anxiety disorders, OCD, substance use disorders, PTSD, cognitive disorders, and sensorimotor deficits, all using artificial intelligence; Surgical and medical apparatus and instruments, namely, electrotherapy stimulation apparatus comprising electrodes for the stimulation of nerves and brain tissue using an electric field, for medical purposes; Electrocorticographic stimulation devices for physical therapy and medical therapy purposes | ACTIVE | — |
| 042 | Medical research; Medical and scientific research in the field of neuropsychiatric disorders including depression, anxiety disorders, OCD, substance use disorders, PTSD, cognitive disorders, and sensorimotor deficits, brain wave sensing and stimulation, brain/computer interface, all using artificial intelligence; Compiling data for research purposes in the field of medical science and medical consultancy; Providing temporary use of non-downloadable computer software in the field of data management for processing medical data, patient data, and demographic data, namely, data acquisition, data visualization, automatic data analysis, statistic data analysis, automated report generation, comparative data analysis, data export/import, data searching, data synchronization tools, using artificial intelligence | ACTIVE | — |
| 044 | Medical care; Provision of medical services by health care professionals via the internet or telecommunication networks; Remote monitoring of medical data for medical diagnosis and treatment; Providing medical information in the fields of neuropsychiatric disorders including depression, anxiety disorders, OCD, substance use disorders, PTSD, cognitive disorders, and sensorimotor deficits, brain wave stimulation, and brain-computer interface; Medical diagnostic testing, monitoring and reporting services using artificial intelligence; Medical treatment of neuropsychiatric disorders including depression, anxiety disorders, OCD, substance use disorders, PTSD, cognitive disorders, and sensorimotor deficits; Surgical implantation of subcutaneous microchips into humans; Medical services for treatment of neuropsychiatric disorders, including depression, anxiety disorders, OCD, substance use disorders, PTSD, cognitive disorders, and sensorimotor deficits | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 29, 2026 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Oct 29, 2026 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Jul 30, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 30, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 30, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 13, 2026 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Oct 22, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Apr 21, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Oct 21, 2024 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 21, 2024 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 21, 2024 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Oct 14, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 13, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 13, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 17, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 17, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 17, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 12, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 18, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 13, 2023 | NWAP | NEW APPLICATION ENTERED | — |